Brain-Derived Neurotrophic Factor in Pediatric Acquired Brain Injury and Recovery.
Biomolecules
; 14(2)2024 Feb 04.
Article
en En
| MEDLINE
| ID: mdl-38397427
ABSTRACT
We review emerging preclinical and clinical evidence regarding brain-derived neurotrophic factor (BDNF) protein, genotype, and DNA methylation (DNAm) as biomarkers of outcomes in three important etiologies of pediatric acquired brain injury (ABI), traumatic brain injury, global cerebral ischemia, and stroke. We also summarize evidence suggesting that BDNF is (1) involved in the biological embedding of the psychosocial environment, (2) responsive to rehabilitative therapies, and (3) potentially modifiable. BDNF's unique potential as a biomarker of neuroplasticity and neural repair that is reflective of and responsive to both pre- and post-injury environmental influences separates it from traditional protein biomarkers of structural brain injury with exciting potential to advance pediatric ABI management by increasing the accuracy of prognostic tools and informing clinical decision making through the monitoring of therapeutic effects.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Lesiones Encefálicas
/
Accidente Cerebrovascular
/
Lesiones Traumáticas del Encéfalo
Idioma:
En
Revista:
Biomolecules
Año:
2024
Tipo del documento:
Article